President's Action On Embryos Drawing Fire From Scientists

Clinton's ban on funds for most studies using fertilized human eggs short-circuits NIH'spolicy-making process Many scientists studying human reproduction and embryology are angry and disappointed over a recent White House move to preclude federal funding for most research involving human embryos--new support that had been recommended by an expert panel. They see the move as an attempt to appease the new conservative ma-jority in Congress, which has threatened legislation against such studies

Written byFranklin Hoke
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share


Clinton's ban on funds for most studies using fertilized human eggs short-circuits NIH'spolicy-making process

Many scientists studying human reproduction and embryology are angry and disappointed over a recent White House move to preclude federal funding for most research involving human embryos--new support that had been recommended by an expert panel. They see the move as an attempt to appease the new conservative ma-jority in Congress, which has threatened legislation against such studies.

They say promising work--on fertility, birth defects, development, and cancer--will go forward, but much more slowly than it otherwise might have (see story on page 6). The burden of funding for such investigations will continue to be borne unfairly by infertile couples seeking help from in vitro fertilization clinics in conceiving a child, they claim, as has been the case for many years.

President Bill Clinton's December 2 statement specifically blocked the National Institutes of Health from providing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies